PCSA

SEC source: 0000897069-26-000910 · form4.xml · nonDerivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,492

SEC source: 0000897069-26-000902 · form4.xml · nonDerivative · entry 1

SKIBSTED RUSSELL · CIK 0001308105 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,308

SEC source: 0000897069-26-000912 · form4.xml · nonDerivative · entry 1

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,107

SEC source: 0000897069-26-000979 · form4a.xml · nonDerivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,979

SEC source: 0000897069-26-001167 · form4a.xml · nonDerivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,979

SEC source: 0000897069-26-000752 · form4.xml · nonDerivative · entry 1

Pannu Geraldine · CIK 0001817209 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,188

SEC source: 0000897069-26-000745 · form4.xml · nonDerivative · entry 1

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,110

SEC source: 0000897069-26-000747 · form4.xml · nonDerivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,356

SEC source: 0000897069-26-000743 · form4.xml · nonDerivative · entry 1

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,711

SEC source: 0000897069-26-000741 · form4.xml · nonDerivative · entry 1

Baluch Khoso · CIK 0001686223 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,325

SEC source: 0000897069-26-000750 · form4.xml · nonDerivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,649

SEC source: 0000897069-26-000754 · form4.xml · nonDerivative · entry 1

SKIBSTED RUSSELL · CIK 0001308105 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,324

SEC source: 0000897069-26-000756 · form4.xml · nonDerivative · entry 1

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,562

SEC source: 0000897069-26-000781 · form4.xml · nonDerivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 818

SEC source: 0000897069-26-000977 · form4a.xml · nonDerivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,136

SEC source: 0000897069-26-000220 · form4.xml · derivative · entry 3

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Distribution of vested restricted shares.

F1 · derivative.expiration_date: Distribution of vested restricted shares.

SEC source: 0000897069-26-000220 · form4.xml · nonDerivative · entry 1

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Distribution of vested restricted shares.

SEC source: 0000897069-26-000222 · form4.xml · derivative · entry 3

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Distribution of vested restricted shares.

F1 · derivative.expiration_date: Distribution of vested restricted shares.

SEC source: 0000897069-26-000222 · form4.xml · nonDerivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Distribution of vested restricted shares.

SEC source: 0000897069-26-000218 · form4.xml · derivative · entry 3

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Distribution of vested restricted shares.

F1 · derivative.expiration_date: Distribution of vested restricted shares.

SEC source: 0000897069-26-000218 · form4.xml · nonDerivative · entry 1

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Distribution of vested restricted shares.

SEC source: 0000897069-26-000224 · form4.xml · derivative · entry 5

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Distribution of vested restricted shares.

F1 · derivative.expiration_date: Distribution of vested restricted shares.

SEC source: 0000897069-26-000224 · form4.xml · nonDerivative · entry 1

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Distribution of vested restricted shares.

SEC source: 0000897069-25-001557 · form4.xml · derivative · entry 2

Pannu Geraldine · CIK 0001817209 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001557 · form4.xml · derivative · entry 1

Pannu Geraldine · CIK 0001817209 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001553 · form4.xml · derivative · entry 2

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001553 · form4.xml · derivative · entry 1

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001551 · form4.xml · derivative · entry 2

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,000

Underlying: Common Stock · 204,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001551 · form4.xml · derivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001549 · form4.xml · derivative · entry 2

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,000

Underlying: Common Stock · 288,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001549 · form4.xml · derivative · entry 1

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,000

Underlying: Common Stock · 96,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001559 · form4.xml · derivative · entry 2

Baluch Khoso · CIK 0001686223 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001559 · form4.xml · derivative · entry 1

Baluch Khoso · CIK 0001686223 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001543 · form4.xml · derivative · entry 2

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 768,000

Underlying: Common Stock · 768,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001543 · form4.xml · derivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,000

Underlying: Common Stock · 256,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001547 · form4.xml · derivative · entry 2

SKIBSTED RUSSELL · CIK 0001308105 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,000

Underlying: Common Stock · 324,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001547 · form4.xml · derivative · entry 1

SKIBSTED RUSSELL · CIK 0001308105 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,000

Underlying: Common Stock · 108,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001555 · form4.xml · derivative · entry 2

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001555 · form4.xml · derivative · entry 1

Yorke Justin W · CIK 0001361896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001545 · form4.xml · derivative · entry 2

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,000

Underlying: Common Stock · 333,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001545 · form4.xml · derivative · entry 1

Young David · CIK 0001378166 · Director · Pres. Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,000

Underlying: Common Stock · 111,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001561 · form4.xml · derivative · entry 2

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires not disclosed

F2 · derivative.exercise_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2 · derivative.expiration_date: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

SEC source: 0000897069-25-001561 · form4.xml · derivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

F1 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028.

SEC source: 0000897069-25-001207 · form4.xml · derivative · entry 1

Pannu Geraldine · CIK 0001817209 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,505

Underlying: Common Stock · 175,299 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.

F2 · derivative.expiration_date: The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.

SEC source: 0000897069-25-001223 · form4.xml · derivative · entry 1

Guy Wendy · CIK 0001799360 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,376,478

Underlying: Common Stock · 1,366,046 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,349,245 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

SEC source: 0000897069-25-001221 · form4.xml · derivative · entry 1

Lin Patrick · CIK 0001799363 · Chief Business - Strategy Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,412,082

Underlying: Common Stock · 1,401,650 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,384,411 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

SEC source: 0000897069-25-001219 · form4.xml · derivative · entry 1

Bigora Sian · CIK 0001799365 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,672,087

Underlying: Common Stock · 1,659,185 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,638,778 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

SEC source: 0000897069-25-001209 · form4.xml · derivative · entry 1

Baluch Khoso · CIK 0001686223 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,505

Underlying: Common Stock · 175,299 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.

F2 · derivative.expiration_date: The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.

SEC source: 0000897069-25-001213 · form4.xml · derivative · entry 1

Ng George K · CIK 0001638744 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,922,471

Underlying: Common Stock · 1,822,471 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,859,318 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

SEC source: 0000897069-25-001217 · form4.xml · derivative · entry 1

SKIBSTED RUSSELL · CIK 0001308105 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,803,044

Underlying: Common Stock · 1,775,044 shares

Expires not disclosed

F1 · shares: Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,753,212 shares are subject to stockholder approval of the revised Omnibus Plan.

F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.

F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.